The global diffusion of non-communicable diseases

Author(s):  
Ronald Labonté ◽  
Arne Ruckert

Notwithstanding the threat of infectious pandemics, non-communicable diseases (NCDs) are now the leading cause of preventable mortality and morbidity in all regions of the world except Africa. The rise in NCDs, especially in the developing world, is very much a result of global market integration, trade and investment liberalization, and the growth in the reach and power of transnational corporations whose stock-in-trade are health-harmful commodities (tobacco, alcohol, and obesogenic foods). The modern global governance challenge of what are now referred to as the ‘commercial determinants of health’ is the extent to which such commodities are regulated by governments, passed over to corporate social (self-) responsibility, or seen as an amalgam of the poor lifestyles of individuals in need of a behavioural ‘nudge’. The World Health Organization, the lead international organization developing responses to the NCD threat, must confront powerful member nations representing powerful corporate interests resistant to regulatory change.

2017 ◽  
Vol 87 (1) ◽  
Author(s):  
Bruno Balbi ◽  
Claudio Marcassa ◽  
Fabrizio Pisani ◽  
Giacomo Corica ◽  
Antonio Spanevello

Chronic degenerative non-communicable diseases affecting different organs and systems are considered by the World Health Organization (WHO) as the emergent epidemic in the third millennium...


This chapter includes a brief overview of musculoskeletal conditions which are described in health terms as non-communicable diseases. Health systems internationally share common goals of improving the health and well-being of their populations and the management of non-communicable diseases is key in every country. This chapter describes how across the world governments share significant challenges for the future, with the growing elderly and chronic disease populations and increasing healthcare costs. Agreed international goals have been set by the World Health Organization and some of the key targets are outlined. The consequences of either trauma or disease can result in a musculoskeletal condition that may impact the individual’s quality of life, health, and functional ability. The role of the nurse and how individual nurses in all care sectors should consider public health factors when caring for patients are discussed.


2020 ◽  
Vol 25 (11) ◽  
pp. 4347-4350
Author(s):  
Subhash Janardhan Bhore

Abstract On 31st May of every year, in honour of the ‘World No Tobacco Day (WNTD),’ the international community does organise various events and encourages avoiding all forms of Tobacco consumption. To commemorate WNTD-2018, the World Health Organization (WHO) has promoted awareness to highlight the link between Tobacco and cardiovascular disease (CVD). Because, Tobacco use is the second leading cause of CVD, after high blood pressure. In addition to CVD, Tobacco use is also known to cause many non-communicable diseases, including chronic obstructive pulmonary disease (COPD), lung cancer and other complicated disorders caused by smoking. In fact, non-communicable diseases are now emerging as the primary disease burden. Globally, Tobacco use kills about 7 million people each year, and if the trend remains the same, then it will kill more than 8 million people per year by 2030. On the contrary, despite promoting awareness, the Tobacco industry is growing with little or no regulation. However, in the long run, the global community will not be able to afford business as usual as Tobacco has a direct impact on human health, environmental health and sustainable development.


Subject Latin America's most serious health challenge -- obesity. Significance The growth of obesity in Latin America has made the issue one of the most important in the region. More than half of the population is overweight to some degree, according to the standards established by the World Health Organization (WHO). As a result, governments have had to take action to address the problem and its effects, which are putting health systems in a state of financial crisis. Impacts Demand for treatment for non-communicable diseases will increase regionwide, placing a strain on health budgets. Increasing pressures on health budgets may encourage further privatisation of services. High revenues make any repeal of Mexico's sugar tax extremely unlikely despite pressure from industry bodies.


Antioxidants ◽  
2020 ◽  
Vol 9 (4) ◽  
pp. 290
Author(s):  
Chiara Nediani ◽  
Lisa Giovannelli

As recently reported by the World Health Organization (WHO), Non-Communicable Diseases (NCDs) has been rising over the last century representing the main cause of death and disability for the general population regardless of age, region, or gender [...]


2016 ◽  
Vol 7 (3) ◽  
pp. 597-603
Author(s):  
Paolo R. Vergano ◽  
Blanca Salas Ferrer

According to the World Health Organization (hereinafter, WHO), 38 million people die each year as a consequence of non-communicable diseases (hereinafter, NCDs). NCDs are mainly caused by diet-related factors, but also by physical inactivity and abuse of certain substances. In particular, overweight and obesity reportedly affect more than 10% of men and 14% of women globally and kill as many as 2.8 million people every year.


Author(s):  
Roger Magnusson

Non-communicable diseases (NCDs), including cardiovascular disease, cancer, chronic respiratory diseases, and diabetes, are responsible for around 70 percent of global deaths each year. This chapter describes how NCDs have become prevalent and critically evaluates global efforts to address NCDs and their risk factors, with a particular focus on the World Health Organization (WHO) and United Nations (UN) system. It explores the factors that have prevented those addressing NCDs from achieving access to resources and a priority commensurate with their impact on people’s lives. The chapter evaluates the global response to NCDs both prior to and since the UN High-Level Meeting on Prevention and Control of Non-communicable Diseases, held in 2011, and considers opportunities for strengthening that response in future.


Author(s):  
E V Lambert

Chronic, non-communicable diseases (NCDs) account for more than two-thirds of global mortality, at least 50% of which is preventable on the basis of modifiable lifestyle behaviours. In the wake of the UN Global Summit on NCDs, the World Health Organization produced a discussion paper that emphasised the need for a global monitoring framework and voluntary global targets for the prevention and control of NCDs.1 The WHO discussion paper presents 10 suggested voluntary targets including the reduction in deaths due to NCDs, cardiovascular disease and diabetes, an overall reduction in blood pressure and obesity, as well as reduced smoking, alcohol and dietary salt intake, increased screening for cervical cancer and the elimination of trans-fats from the food supply. Physical activity is notable by its absence from this critical list of voluntary global targets for preventing and controlling NCDs


2020 ◽  
Vol 8 ◽  
Author(s):  
Bapi Gorain ◽  
Hira Choudhury ◽  
Nagashekhara Molugulu ◽  
Rajani B. Athawale ◽  
Prashant Kesharwani

Sudden outbreak of a new pathogen in numbers of pneumonic patients in Wuhan province during December 2019 has threatened the world population within a short period of its occurrence. This respiratory tract–isolated pathogen was initially named as novel coronavirus 2019 (nCoV-2019), but later termed as SARS-CoV-2. The rapid spreading of this infectious disease received the label of pandemic by the World Health Organization within 4 months of its occurrence, which still seeks continuous attention of the researchers to prevent the spread and for cure of the infected patients. The propagation of the disease has been recorded in 215 countries, with more than 25.5 million cases and a death toll of more than 0.85 million. Several measures are taken to control the disease transmission, and researchers are actively engaged in finding suitable therapeutics to effectively control the disease to minimize the mortality and morbidity rates. Several existing potential candidates were explored in the prevention and treatment of worsening condition of COVID-19 patients; however, none of the formulation has been approved for the treatment but used under medical supervision. In this article, a focus has been made to highlight on current epidemiology on the COVID-19 infection, clinical features, diagnosis, and transmission, with special emphasis on treatment measures of the disease at different stages of clinical research and the global economic influence due to this pandemic situation. Progress in the development on vaccine against COVID-19 has also been explored as important measures to immunize people. Moreover, this article is expected to provide information to the researchers, who are constantly combating in the management against this outbreak.


Sign in / Sign up

Export Citation Format

Share Document